CorMatrix Cor TRICUSPID ECM Valve Replacement Study

Status Recruiting

Clinical Trial Summary

The Pivotal Study of the Cor TRICUSPID ECM Valve (or Cor PEDIATRIC Tricuspid ECM Valve). This study follows the EFS and is now to determine the safety and efficacy of the Cormatrix Cor TRICUSPID Valve for any patients requiring surgical replacement of the tricuspid valve.

Clinical Trial Description

CorMatrix Cardiovascular, Inc. has developed a device for heart valve replacement, the CorMatrix® Cor ECM® Tricuspid Valve, which can be implanted to replace dysfunctional tricuspid heart valves. This Pivotal Study is being performed to verify the ability to successfully implant the Tricuspid Valve, the clinical safety of the device, and whether the device performs its intended use. The study is a multi-center, prospective, single-arm, Pivotal Study of subjects receiving the Cor TRICUSPID ECM Valve or Cor PEDIATRIC Tricuspid ECM Valve. The study will be conducted at up to 15 sites. Up to 60 subjects will undergo tricuspid valve replacement (TVR) with the CorMatrix ECM Valve for the surgical management of tricuspid valve disease. The cohort will include up to 60 adult and 18 pediatric patients. ;

Study Design

Related Conditions & MeSH terms

Tricuspid Valve Disease

Clinical Trial Details

NCT number	NCT02397668
Study type	Interventional
Source	CorMatrix Cardiovascular, Inc.
Contact	Robert G Matheny, MD
Phone	404-276-7777
Email	rmatheny@cormatrix.com
Status	Recruiting
Phase	N/A
Start date	August 1, 2022
Completion date	December 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06001489` - The Effects of 360-degree Virtual Reality on Pre-procedural Anxiety in Patients Awaiting Elective Cardiac Surgery Involving a Sternotomy	N/A
Active, not recruiting	`NCT04950192` - Philips Intracardiac Echocardiography (ICE) Clinical Registry
Terminated	`NCT04665583` - Prehab Prior to Undergoing Tricuspid Intervention
Recruiting	`NCT03546231` - Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation
Recruiting	`NCT05797519` - Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation	N/A
Recruiting	`NCT05913908` - EFS of the DUO System for Tricuspid Regurgitation (TANDEM II)	N/A
Not yet recruiting	`NCT06137807` - TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV)	N/A
Recruiting	`NCT04231461` - Quality of Life After Cardiac Surgery
Completed	`NCT03239262` - Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation	N/A
Recruiting	`NCT06235385` - European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study
Not yet recruiting	`NCT06458907` - TRICAV-II Pivotal: TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation.	N/A
Recruiting	`NCT03859102` - Enhanced Recovery After Cardiac Surgery	N/A
Recruiting	`NCT04097145` - Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial	N/A
Recruiting	`NCT05742906` - CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study	N/A
Recruiting	`NCT05961150` - PROMISE: Percutaneous peRipheral cannulatiOn for Minimally-InvaSive Heart Valve surgEry
Recruiting	`NCT04482062` - TRISCEND II Pivotal Trial	N/A
Active, not recruiting	`NCT05064514` - Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease	N/A
Recruiting	`NCT05848284` - Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)	N/A